Jeffrey Lawson has been appointed CEO of regenerative medicine company Humacyte. Lawson had been chief medical officer of the Research Triangle Park, NC, company since 2015. Lawson’s experience includes several roles at Duke University Medical Center. Former CEO Carrie Cox has taken on the role of executive chairman. Humacyte has developed a way to grow veins in a laboratory. The company is currently in Phase 3 studies testing these veins as an alternative to synthetic blood vessels for kidney failure patients.